‘”In two years, we were able to go from a moonshot idea to developing these therapies to demonstrating that they reverse osteoarthritis in animals,” says chemical and biological engineer Stephanie Bryant, from UC Boulder.

Having completed the first tranche of the animal experiments, the team is ready to move on to phase two. This will gather further data on safety and toxicology, laying the groundwork for human clinical trials….’ (David Nield via ScienceAlert)